Latest period
$48.98B
YoY change
-4.4%
5Y CAGR
-1.1%
Peak year (2015)
$53.23B
Latest annual
$48.02B
Total Equity history chart for Medtronic (MDT) from 1986 to 2025
Latest: $48.02B
Total Equity growth chart for Medtronic (MDT) from 1986 to 2025
Latest: -4.4%
Total Equity history table for Medtronic (MDT) from 1986 to 2025
| 2025 | $48.02B | -4.4% | −$2.19B | ||
| 2024 | $50.21B | -2.5% | −$1.27B | ||
| 2023 | $51.48B | -2.0% | −$1.07B | ||
| 2022 | $52.55B | +2.2% | +$1.12B | ||
| 2021 | $51.43B | +1.4% | +$691.00M | ||
| 2020 | $50.74B | +1.3% | +$646.00M | ||
| 2019 | $50.09B | -1.2% | −$629.00M | ||
| 2018 | $50.72B | +0.8% | +$426.00M | ||
| 2017 | $50.29B | -3.0% | −$1.53B | ||
| 2016 | $51.83B | -2.6% | −$1.40B | ||
| 2015 | $53.23B | +173.8% | +$33.79B | ||
| 2014 | $19.44B | +4.1% | +$772.00M | ||
| 2013 | $18.67B | +9.1% | +$1.56B | ||
| 2012 | $17.11B | +7.2% | +$1.15B | ||
| 2011 | $15.97B | +9.2% | +$1.34B | ||
| 2010 | $14.63B | +13.8% | +$1.78B | ||
| 2009 | $12.85B | +11.4% | +$1.31B | ||
| 2008 | $11.54B | +5.1% | +$559.00M | ||
| 2007 | $10.98B | +17.0% | +$1.59B | ||
| 2006 | $9.38B | -10.2% | −$1.07B | ||
| 2005 | $10.45B | +15.1% | +$1.37B | ||
| 2004 | $9.08B | +14.8% | +$1.17B | ||
| 2003 | $7.91B | +22.9% | +$1.48B | ||
| 2002 | $6.43B | +16.7% | +$921.60M | ||
| 2001 | $5.51B | +22.7% | +$1.02B | ||
| 2000 | $4.49B | +19.1% | +$720.70M | ||
| 1999 | $3.77B | +84.5% | +$1.73B | ||
| 1998 | $2.04B | +17.1% | +$298.00M | ||
| 1997 | $1.75B | -2.4% | −$43.10M | ||
| 1996 | $1.79B | +34.0% | +$454.30M | ||
| 1995 | $1.33B | +26.7% | +$281.50M | ||
| 1994 | $1.05B | +25.2% | +$212.00M | ||
| 1993 | $841.50M | +5.6% | +$45.00M | ||
| 1992 | $796.50M | +16.6% | +$113.30M | ||
| 1991 | $683.20M | +26.3% | +$142.20M | ||
| 1990 | $541.00M | +14.2% | +$67.40M | ||
| 1989 | $473.60M | +19.6% | +$77.70M | ||
| 1988 | $395.90M | +2.3% | +$8.90M | ||
| 1987 | $387.00M | +11.0% | +$38.30M | ||
| 1986 | $348.70M | — | — |
- 2025$48.02B-4.4%
- 2024$50.21B-2.5%
- 2023$51.48B-2.0%
- 2022$52.55B+2.2%
- 2021$51.43B+1.4%
- 2020$50.74B+1.3%
- 2019$50.09B-1.2%
- 2018$50.72B+0.8%
- 2017$50.29B-3.0%
- 2016$51.83B-2.6%
- 2015$53.23B+173.8%
- 2014$19.44B+4.1%
- 2013$18.67B+9.1%
- 2012$17.11B+7.2%
- 2011$15.97B+9.2%
- 2010$14.63B+13.8%
- 2009$12.85B+11.4%
- 2008$11.54B+5.1%
- 2007$10.98B+17.0%
- 2006$9.38B-10.2%
- 2005$10.45B+15.1%
- 2004$9.08B+14.8%
- 2003$7.91B+22.9%
- 2002$6.43B+16.7%
- 2001$5.51B+22.7%
- 2000$4.49B+19.1%
- 1999$3.77B+84.5%
- 1998$2.04B+17.1%
- 1997$1.75B-2.4%
- 1996$1.79B+34.0%
- 1995$1.33B+26.7%
- 1994$1.05B+25.2%
- 1993$841.50M+5.6%
- 1992$796.50M+16.6%
- 1991$683.20M+26.3%
- 1990$541.00M+14.2%
- 1989$473.60M+19.6%
- 1988$395.90M+2.3%
- 1987$387.00M+11.0%
- 1986$348.70M—
Total Equity values are taken from Medtronic's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Medtronic (MDT)
According to Medtronic's latest reported financial statements, the company's latest reported total equity is $48.98B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Medtronic (MDT) total equity is $48.02B – edged down 4.4% year-over-year.
Medtronic total equity compound annual growth for the 2020–2025 (5 years) window is -1.1%, with a net decline across the window.
Medtronic total equity declined from $53.23B in 2015 to $48.02B in 2025, a 9.8% drawdown.
The highest annual total equity of $53.23B was reported in 2015. The lowest in the available history was $348.70M in 1986.
Medtronic Total Equity by Year
Medtronic Total Equity 2025: $48.02B
Medtronic posted total equity of $48.02B in 2025, edged down 4.4% below 2024.
Medtronic Total Equity 2024: $50.21B
In 2024, Medtronic reported total equity of $50.21B, edged down 2.5% below 2023.
Medtronic Total Equity 2023: $51.48B
Medtronic total equity in 2023 was $51.48B, edged down 2.0% below 2022.
Medtronic Total Equity 2022: $52.55B
2022's total equity for Medtronic came in at $52.55B, edged up 2.2% from 2021.
Medtronic Total Equity 2021: $51.43B
Medtronic total equity in 2021 was $51.43B.
See more financial history for Medtronic (MDT).
Sector peers by Total Equity
Healthcare peers of Medtronic (MDT), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Medtronic (MDT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation